October 19, 2006

Mr. Jeffrey Reidler
Assistant Director, Division of Corporation Finance
Securities and Exchange Commission
100 F Street, N.E.
Mail Stop 6010
Washington, D.C. 20549-6010

Re:		Catalyst Pharmaceutical Partners, Inc. Registration Statement on Form S-1 File No. 333-136039

Dear Mr. Reidler:

In connection with the proposed offering of common stock of Catalyst Pharmaceutical Partners, Inc. contemplated by the above-captioned Registration Statement, we wish to advise you that we, as representatives of the underwriters, hereby join with Catalyst Pharmaceutical Partners’ request that the effective date of the above-captioned Registration Statement be accelerated so that the same will become effective on October 23, 2006 at 2:00 P.M., New York City time or as soon as practicable thereafter.

The following is supplemental information supplied under Rule 418(a)(7) and Rule 460 under the Securities Act of 1933:

(i)		Date of preliminary prospectus: October 4, 2006.
(ii)		Dates of distribution: October 4, 2006 — October 23, 2006
(iii)		Number of prospective underwriters and dealers to whom the preliminary prospectus was furnished: 2
(iv)		Number of preliminary prospectuses furnished to others: none
(v)		Number of prospectuses so distributed: approximately 2,200
(vi)		Steps taken to comply with Rule 15c2-8 under the Securities Exchange Act of 1934: Included in Master Agreement Among Underwriters of First Albany Capital Inc.

Very truly yours,

FIRST ALBANY CAPITAL INC.
STIFEL NICOLAUS & COMPANY, INCORPORATED